Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Yesterday, March 26, 2015, 45 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $197.27 to $183,764,684.16.

Highlighted Stocks Traded by Insiders:

VAALCO Energy (EGY) - FREE Research Report

Chapoton O Don, who is Director at VAALCO Energy, bought 5,700 shares at $3.13 on March 26, 2015. Following this transaction, the Director owned 58,134 shares meaning that the stake was boosted by 10.87% with the 5,700-share transaction.

The shares most recently traded at $3.20, up $0.07, or 2.19% since the insider transaction. Historical insider transactions for VAALCO Energy go as follows:

  • 4-Week # shares bought: 67,620
  • 4-Week # shares sold: 26,698
  • 12-Week # shares bought: 67,620
  • 12-Week # shares sold: 26,698
  • 24-Week # shares bought: 67,620
  • 24-Week # shares sold: 26,698

The average volume for VAALCO Energy has been 1.2 million shares per day over the past 30 days. VAALCO Energy has a market cap of $185.2 million and is part of the basic materials sector and energy industry. Shares are down 29.39% year-to-date as of the close of trading on Thursday.

VAALCO Energy, Inc., an independent energy company, acquires, explores for, develops, and produces crude oil and natural gas. Currently, there is 1 analyst who rates VAALCO Energy a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on EGY - FREE

TheStreet Quant Ratings

rates VAALCO Energy as a

sell

. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity, weak operating cash flow, generally disappointing historical performance in the stock itself and feeble growth in its earnings per share. Get the full

VAALCO Energy Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Aetna (AET) - FREE Research Report

Garten Jeffrey E, who is Director at Aetna, sold 18,300 shares at $109.01 on March 26, 2015. Following this transaction, the Director owned 12,848 shares meaning that the stake was reduced by 58.75% with the 18,300-share transaction.

Hackman Franklin Barbara, who is Director at Aetna, sold 3,000 shares at $108.75 on March 26, 2015. Following this transaction, the Director owned 23,007 shares meaning that the stake was reduced by 11.54% with the 3,000-share transaction.

The shares most recently traded at $107.65, down $1.10, or 1.02% since the insider transaction. Historical insider transactions for Aetna go as follows:

  • 4-Week # shares sold: 16,500
  • 12-Week # shares sold: 21,800
  • 24-Week # shares sold: 21,800

The average volume for Aetna has been 2.3 million shares per day over the past 30 days. Aetna has a market cap of $37.4 billion and is part of the health care sector and health services industry. Shares are up 19.23% year-to-date as of the close of trading on Thursday.

Aetna Inc. operates as a health care benefits company in the United States. It operates through three segments: Health Care, Group Insurance, and Large Case Pensions. The stock currently has a dividend yield of 0.93%. The company has a P/E ratio of 18.9. Currently, there are 12 analysts who rate Aetna a buy, no analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on AET - FREE

TheStreet Quant Ratings

rates Aetna as a

buy

. The company's strengths can be seen in multiple areas, such as its solid stock price performance, revenue growth, reasonable valuation levels, largely solid financial position with reasonable debt levels by most measures and notable return on equity. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full

Aetna Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Proofpoint (PFPT) - FREE Research Report

Newell Tracey, who is EVP, Worldwide Sales at Proofpoint, sold 1,000 shares at $54.02 on March 26, 2015. Following this transaction, the EVP, Worldwide Sales owned 10,485 shares meaning that the stake was reduced by 8.71% with the 1,000-share transaction.

The shares most recently traded at $57.49, up $3.47, or 6.03% since the insider transaction. Historical insider transactions for Proofpoint go as follows:

  • 4-Week # shares sold: 74,251
  • 12-Week # shares sold: 105,251
  • 24-Week # shares sold: 125,251

The average volume for Proofpoint has been 488,500 shares per day over the past 30 days. Proofpoint has a market cap of $2.1 billion and is part of the technology sector and computer software & services industry. Shares are up 18.62% year-to-date as of the close of trading on Thursday.

Proofpoint, Inc. provides threat protection, incident response, regulatory compliance, archiving, governance, eDiscovery, and secure communication solutions worldwide. Currently, there are 10 analysts who rate Proofpoint a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on PFPT - FREE

TheStreet Quant Ratings

rates Proofpoint as a

sell

. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity, generally high debt management risk and feeble growth in its earnings per share. Get the full

Proofpoint Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

null